Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
about
At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screeningSimultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissuesThe sweet and sour of serological glycoprotein tumor biomarker quantification.Aberrant glycosylation associated with enzymes as cancer biomarkers.Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.Current and future applications of magnetic resonance imaging (MRI) to breast and ovarian cancer patient management.Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controlsTranslation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges.Sugar nucleotide quantification using multiple reaction monitoring liquid chromatography/tandem mass spectrometry.A specific miRNA signature in the peripheral blood of glioblastoma patients.Identification of miRNAs as potential new biomarkers for nervous system cancer.MicroRNA-200c and microRNA-141 as potential diagnostic and prognostic biomarkers for ovarian cancer.Integrated extracellular microRNA profiling for ovarian cancer screening
P2860
Q33927576-3DCFEC91-AC07-49B4-A8D9-C37F1E644800Q34122840-A722F7FC-4352-4BD2-BC89-EE5485FF849EQ34541208-E3815FE5-8458-4195-B4B4-C0602E79A514Q34580285-F8ECD165-48BE-4DD1-BB4E-0B2DDD96BC3BQ35206309-79DF8E91-844F-4D04-B310-B14636BF104EQ35761001-6BAE9D81-610E-48B7-BDC0-0BFDE7E497D7Q36136098-2FDF1C6B-25BB-444E-92EA-FBC8490A893EQ36197710-592DDC92-BCB9-4F5F-A2A7-A0B845643DA5Q37358998-14930E3A-6E70-41BF-9380-A390978F61FEQ37363395-F5CBB4B7-BF19-4332-89FD-FF657320FEA4Q39131238-B363FFEF-674B-4C35-BB7B-74B07799ABFAQ45256953-34D8C454-34E8-4563-81A9-DE54F7D616D1Q48595509-0E72774F-6B41-41CE-B8E9-1965D9B0E1FFQ51061144-B2F89267-B7D0-4BCC-A8B8-284D9260A98DQ58547195-6A39EDD8-77E8-45B2-BAA8-2EF99273EAE8
P2860
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@en
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@nl
type
label
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@en
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@nl
prefLabel
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@en
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@nl
P2093
P2860
P1476
Early Detection of Cancer: Immunoassays for Plasma Tumor Markers.
@en
P2093
Daniel W Chan
Danni L Meany
Lori J Sokoll
P2860
P304
P356
10.1517/17530050903266830
P407
P577
2009-11-01T00:00:00Z